Market Insights

FY 2023 – H1 2024 Preclinical CRO Market

Hospital @ Home

The Transformation of Virtual Care

Pharma Contract Services Industry Outlook 2023

Highlights, Trends, Opportunities & Outlook

2023 & 2024 Life Science Market Outlook

Highlights, Trends, Opportunities & Outlook

2023 Artificial Intelligence in Life Sciences Market Insight

Highlights, Trends, Opportunities & Outlook

2023 Life Sciences & Healthcare Consulting Market Insight

Highlights, Trends, Opportunities & Outlook

Strategic Survival During A Downturn

How The HealthTech Industry Is Entering A (Probable) Recession, And Ways Management Teams Can Navigate Newly Unchartered Waters

2022 Pharma Contract Services Industry Outlook

Outcome Capital shares their analysis and insights on pivotal trends and opportunities within the Pharma Contract Services sector.

2022 Digital Health Sector: Highlights, Trends & Opportunities

Outcome Capital shares their analysis and insights on pivotal trends and opportunities within the Digital Health sector.

2022 Medical Device Sector: Highlights, Trends & Opportunities

Outcome Capital shares their views, insights and data on key strategic trends and dynamics in the Medical Device sector.

2022 Biopharma Industry Outlook: Highlights, Trends & Opportunities

Outcome Capital shares their views, insights and data on key strategic trends and dynamics in the biopharma sector. This segment is poised for significant growth, scientific advancement and consolidation.

2022 Life Science Consulting Sector: Market Trends, Dynamics & Opportunities

Outcome Capital shares their views, insights and data on key strategic trends and dynamics in the life science consulting sector. This vibrant segment is poised for significant growth and consolidation.

Digital Health Sector: Trends and Opportunities

Outcome Capital shares their views, insights and data on key strategic and financial trends within the Virtual Care, Population Health and Tech-Enabled Payor segments. These vibrant segment niches of the broader Digital Health industry are poised for significant investment and consolidation.

Biology & Digital Technology Merger Gives Rise to Spatial Biology

As a highly specialized life science advisory and investment banking firm, Outcome Capital looks to identify emerging trends that effect how researchers and clinicians understand, diagnose, and treat disease.

Shining the Light on Diagnostic Shortcomings During the COVID Pandemic Reveals a Stronger Path for the Future

Outcome Capital sat down and spoke with Dr. Cathy Petti to get her perspective on the shortcomings of COVID diagnosis and how to carve out a stronger path for the future. 

Grabbing Hold of the COVID-19 Pandemic as a Diagnostic Company

Outcome Capital sat down and spoke with Chuck Morrison to get his thoughts on the effects of the current COVID-19 pandemic on diagnostic transactional activity in 2020 and how best to weather the economic environment.

In Vitro Diagnostic Market Insight: Continued Growth and Consolidation

The In Vitro Diagnostic market values established companies with regulatory approval and market traction. This is demonstrated by premiums paid for acquisitions of companies that offer the opportunity to quickly capture market share and IPOs of companies with significant revenues.

Update in Immuno-Oncology: Multiplicity of Drug In-Licensing Opportunities to Expand Your Pipeline

This market update captures assets currently in development and recent partnering/in-licensing transactions which can catalyze development and improve valuation for companies.

Ophthalmology Market: Opportunity for Growth Remains

The ophthalmology market values innovation approaches, demonstrated by premiums paid for acquisition of  first-in-class therapies and public market support of ophthalmology gene therapy companies.

Cell-based Therapies: A Maturing Market Poised for Growth

The cell-based therapy market will grow significantly, supported by recent clarity in the FDA pathway, improved clinical outcomes as well as market entry by big pharma.